Dog viste kliniske data fra RESIST- studiet ingen signifikant ændring af sikkerhedsprofilen, når tipranavir/ ritonavir gives med eller uden enfuvirtid.
Nevertheless, the clinical data available from the RESIST trials did not suggest any significant alteration of the tipranavir/ ritonavir safety profile when combined with enfuvirtide as compared to patients treated with tipranavir/ ritonavir without enfuvirtide.